Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer. [electronic resource]
Producer: 20200622Description: e1911895 p. digitalISSN:- 2574-3805
- Aged
- Antineoplastic Agents, Immunological
- Ataxia Telangiectasia -- genetics
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cohort Studies
- DNA Mutational Analysis
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Prognosis
- Treatment Outcome
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.